Characteristics and Outcome of Patients Hospitalised for Lower Extremity Peripheral Artery Disease in France: The COPART Registry
- 31 May 2010
- journal article
- research article
- Published by Elsevier BV in European Journal of Vascular and Endovascular Surgery
- Vol. 39 (5), 577-585
- https://doi.org/10.1016/j.ejvs.2010.02.009
Abstract
No abstract availableKeywords
Funding Information
- French Vascular Medicine Society (SFMV)
- AstraZeneca France
- Bayer France
- Bristol–Myers–Squibb France
- Sanofi–Aventis France
This publication has 21 references indexed in Scilit:
- Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) RegistryAtherosclerosis, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional studyInternational Journal of Clinical Practice, 2008
- Patients with peripheral arterial disease in the CHARISMA trialEuropean Heart Journal, 2008
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)European Journal of Vascular and Endovascular Surgery, 2007
- Rosuvastatin in Older Patients with Systolic Heart FailureThe New England Journal of Medicine, 2007
- The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial diseaseJournal of Vascular Surgery, 2007
- Peripheral arterial disease versus other localizations of vascular disease: The ATTEST studyJournal of Vascular Surgery, 2006
- The Lack of Cardiovascular Risk Factor Management in Patients with Critical Limb IschaemiaEuropean Journal of Vascular and Endovascular Surgery, 2001
- Clinical Outcome and its Predictors in 1560 Patients with Critical Leg IschaemiaEuropean Journal of Vascular and Endovascular Surgery, 1999